Search alternatives:
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
4861
-
4862
-
4863
-
4864
-
4865
Overexpression of Atp13a2 protects cells from manganese cytotoxicity.
Published 2019“…<p>(A-B) HeLa cells or HeLa cells stably expressing V5-tagged Atp13a2 were grown under normal growth conditions (a and e) or were exposed to 500 μM (b and f) or 800 μM MnCl<sub>2</sub> for 16 or 24 hours (c, d, g and h) prior to cell death analysis. …”
-
4866
-
4867
-
4868
-
4869
-
4870
-
4871
-
4872
Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators
Published 2022“…We previously reported 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amines as A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) positive allosteric modulators (PAMs). …”
-
4873
Structure–Activity Studies of 1<i>H</i>‑Imidazo[4,5‑<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators
Published 2022“…We previously reported 1<i>H</i>-imidazo[4,5-<i>c</i>]quinolin-4-amines as A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) positive allosteric modulators (PAMs). …”
-
4874
-
4875
-
4876
A391V is a potential pathogenic allele.
Published 2016“…<p>(A) Sanger Sequence confirmation of the 1172 C>T point mutation in Gas8<sup>AV</sup> mice reproducing the A391V missense mutation found in the human patient. …”
-
4877
<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation.
Published 2025“…<b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …”
-
4878
-
4879
-
4880